Rockwell Automation ROK
Industrials · Industrial - Machinery · Synthos Deep Dive · 2026-07-03
The Overview
Rockwell Automation makes the "brains and muscles" of factories — the controllers, drives, sensors, and software that run automated production lines for carmakers, food and drink plants, warehouses, chip fabs, and data centers. If a modern factory in North America moves a robot arm or a conveyor, there's a good chance Rockwell gear is behind it. It's a very good business: it keeps about 52 cents of gross profit on every sales dollar and earns high returns.
The catch: the stock is expensive and the business is cyclical — it rises and falls with how much money companies are spending on new factories. Right now spending is recovering, which is good, but you're paying roughly $36 for every $1 of next year's earnings for a company only growing sales about 5% a year. That's a premium price for modest growth. Our verdict is Watch — wait for a better price or faster growth.
Here's what our three scores mean in everyday terms:
- Downside Risk 6/10 (a bit above average). Solid company, but the stock swings more than the market (it's cyclical), carries some debt, and is priced high — so a stumble hurts.
- Growth Quality 5/10 (middle). Excellent profitability and a real moat, but the growth is slow and depends on the economy.
- Exponential Potential 3/10 (low). This is a steady, mature industrial — not a company that doubles quickly.
The one big worry: factory and capital spending is cyclical. If orders roll over in a slowdown, both earnings and the rich multiple can fall at the same time.
Putting a number on it: our fair-value estimate is $465 against a current price of $430.86 — real upside if our numbers are right.
Our summary metrics
Beta 1.56 & 2.2× net-debt/EBITDA in a cyclical, priced 36× fwd EPS — rich for mid-single-digit growth.
Only ~5% fwd revenue CAGR & ~9% fwd EPS CAGR, but 52% gross margin, 30% ROE and a genuine software/ARR mix-shift.
Late-cycle industrial compounder, not an exponential; $52B cap in a mature TAM, growth re-accelerating off a trough but not inflecting.
What does “fair value” mean?
Fair value is Synthos’s estimate of what one share is worth today, based on our model of the company’s future cash generation and the risks to it. It is not a price target or a prediction of where the stock trades next quarter — it’s the price where we think risk and reward are balanced. Above it, you’re paying for outcomes better than our base case; below it, the market is offering a margin of safety.
The model’s inputs and weightings are proprietary — they’re the product. What we publish is the output, plus an independent, public-math cross-check further down the page (“Check our number”) so you can judge it for yourself.
What do the 5 tiers mean? (Core · Tactical · Watch · Hold · Avoid)
Exponential Potential
Late-cycle industrial compounder, not an exponential; $52B cap in a mature TAM, growth re-accelerating off a trough but not inflecting.
What could take this further than the base case — and where the market may be underpricing it. Full forward-growth and acceleration math in Deeper analysis, §4 below.
Deeper analysis
Technicals, fundamentals, valuation, and the full expert-claim evidence panel — the detail behind the numbers above.
Reference table
| Street consensus | $475 (high $525 / low $410; median $490; 12 Buy · 25 Hold · 2 Sell = Hold) — context, not our anchor |
| Valuation | 49× trailing GAAP EPS · ~36× FY26E · ~32× FY27E · ~26× FY30E · EV/S 6.4× · EV/EBITDA 34× |
| Technicals | Uptrend — $471.70, −4.7% off 52-wk high, above 50/200-DMA, RSI 56, +39% 12-mo (SPY +21%) |
| Conviction | Low — 0 expert voices, 0 KB claims; the call rests entirely on fundamentals + quant |
| Position sizing | Watchlist / small satellite only until valuation resets or growth re-accelerates |
What the experts actually said
No independent expert claims in the Synthos knowledge base yet for ROK — this dive is fundamentals- and technicals-driven, not panel-driven.
Price & moving averages 12 months · 50 & 200-day averages · 52-week range
Solid line = price · dashed line = 50-day average · dotted line = 200-day average · the two thin horizontal lines mark the 52-week high and low. Price above both averages is an uptrend.
Data summary: last close $430.86, 6% below the 50-day average ($458), 3% above the 200-day average ($419) — a mixed trend. 13% below the 52-week high of $495, 29% above the 52-week low of $334.
Bollinger Bands 20-day average ± 2 standard deviations
The shaded band widens when the stock gets more volatile. Riding the upper edge = strong momentum (sometimes stretched); the lower edge = weak / potentially oversold.
Data summary: price $430.86 is currently inside the band (band $418–$464).
RSI (14) momentum gauge · 0–100
Above 70 (overbought zone, shaded) = overbought, below 30 (oversold zone, shaded) = oversold. Currently 40.
MACD 12 / 26 / 9 · trend & momentum
The MACD line crossing above the signal line (bars flip to the up color) = momentum turning up; crossing below (bars flip to the down color) = turning down. Bar height = the size of that gap.
Data summary: MACD is currently below its signal line by 0.52, negative momentum.
Relative performance vs S&P 500 & its sector (XLI (sector)), set to 100 a year ago
Solid = ROK · dashed = S&P 500 · dotted = XLI (sector). A rising line means it is beating that benchmark — the sector line shows whether it is a leader or laggard within its own group.
Forward revenue & earnings actual → estimate · "FY" = fiscal year, "E" = estimate
Darker bars = actual results, brighter = analyst estimates. Taller bars to the right = expected growth.
Key stats an RIA wants
1. What it is
Rockwell Automation (NYSE: ROK), founded 1903 and headquartered in Milwaukee, is the largest pure-play industrial-automation company in the US. It sells the hardware, software, and services that automate discrete, hybrid, and process manufacturing — programmable controllers (the Allen-Bradley / Logix franchise), drives and motion, sensing and safety, plus a growing layer of control software, digital-twin/simulation, cybersecurity, and connected lifecycle services. Fiscal year ends September 30. CEO Blake Moret; ~27,000 employees.
Revenue mix (FY2025, from filings):
- By segment: Intelligent Devices $3.76B (45%) · Software & Control $2.38B (29%) · Lifecycle Services $2.20B (26%). The mix-shift that matters: Software & Control grew fastest (Q2 FY26 +20% YoY, 35% segment margin) and annual recurring revenue (ARR) grew ~6% YoY — a slow, real pivot from a box-mover toward higher-quality recurring/software economics.
- By geography: North America $5.27B (~63%) (US alone ~$4.85B, ~58%) · EMEA $1.49B (18%) · Asia-Pacific $1.02B (12%) · Latin America $0.56B (7%). The base is heavily North-America-weighted, which is a re-shoring/US-capex tailwind but also a concentration risk (§11).
The demand drivers Rockwell keeps naming: warehouse/logistics automation, data-center buildout, semiconductor capacity, and energy — offset by "muted" capital investment in several other verticals.
2. The expert thesis — why the panel is (not) bullish
There is no expert coverage of ROK in the Synthos knowledge base. total_claims = 0, breadth = 0 net-bullish voices, net conviction = 0. No distilled expert has a traceable, dated view on Rockwell in our system.
That matters for honesty: this note carries no conviction-track signal. Every judgment below is derived from the fundamentals (FMP filings), analyst estimates, management's own SEC-filed guidance, and quant/technical data — not from any expert we track. Where the Street has a view we show it as context (a Hold consensus, §6), and we do not dress quant output up as expert conviction. If and when a tracked voice initiates on ROK, this section — and possibly the verdict — will be revisited.
3. Synthos scores & the Bull / Base / Bear cases
The one-glance judgment — three scores, 0–10, each anchored to real metrics (not probabilities we can't honestly calibrate):
| Score | 0–10 | The read |
|---|---|---|
| Downside Risk (lower = safer) | 6 · Moderate-High | Beta 1.56 and net-debt/EBITDA ~2.2× in a cyclical business, priced ~36× forward EPS for ~5% revenue growth. Balance sheet is investment-grade and serviceable (interest coverage ~12×), but valuation + cyclicality leave real room to fall in a downturn. |
| Growth Quality | 5 · Average | Only ~5% forward revenue CAGR and ~9% forward EPS CAGR — modest — but 52% gross margin, ~30% ROE, ~16% ROIC, a wide Allen-Bradley moat, and a genuine software/ARR mix-shift lift the quality of that growth well above its rate. |
| Exponential Potential | 3 · Low | A mature, late-cycle industrial compounder. Growth is re-accelerating off a FY25 trough (good) but not inflecting into a new curve; a $52B cap in a mature automation TAM caps the multibagger. Own for durable mid-single-digit compounding, not exponentiality. |
The three cases (our own scenario model — assumptions shown; each target is a ~12–18-month fair value). We deliberately do not attach probabilities: the base case is by definition the expected path, so a weighted blend would just restate it with false precision. The cases bound the range; the scores above summarize them.
| Case | Key assumptions | Fair value |
|---|---|---|
| Bull | Capex cycle inflects up; re-shoring + data-center/semi demand drives organic sales toward the high end; ARR/software mix lifts margins. FY27E adj. EPS beats to ~$16 (vs ~$14.5 cons); market pays a peak-cycle ~36×. | ~$585 (+24%) |
| Base (our anchor) | Estimates roughly hit — FY27E EPS ~$14.5; a high-quality but slow-growth cyclical earns a ~32× forward multiple. | ~$465 (−1%) |
| Bear | Cyclical rollover: capex pauses, organic sales flatten/decline, ARR growth stalls. FY27E EPS misses to ~$12.5; multiple de-rates to a mid-cycle ~28×. | ~$355 (−25%) |
Synthos fair value = the base case, ~$465 (−1%), with the full $355–$585 span as the honest range. Our base sits essentially on top of the Street's $475 consensus (this is a well-covered, efficiently-priced megacap; we have no differentiated edge to claim), while our bear takes the cyclicality seriously. This is a tracked call — the Forecaster Scorecard grades it once it matures.
4. Exponential Potential
Synthos separates compounders (durable high returns on capital) from exponentials (accelerating, multi-baggers-from-here). ROK is a high-quality compounder with low exponential potential:
- Forward growth (modest): revenue CAGR FY25→FY30E ~5.4% ($8.34B → $10.87B); EPS CAGR off the FY26E base ~9% ($12.98 → $18.49 by FY30E) as margins and mix improve. These are respectable industrial numbers, not exponential ones.
- Acceleration (the 2nd derivative) is positive off a trough — but not an inflection. Revenue fell to $8.34B in FY25 (below FY23's $9.06B) as the automation capex cycle bottomed; it now re-accelerates (Q2 FY26 sales +12% reported, +9% organic). This is a cyclical recovery, not a structural new-curve inflection like a genuine exponential. Per our flagship philosophy we pick forward next-exponentials over trailing compounders — ROK is squarely a compounder.
- Room to run (limited): the industrial-automation TAM is large but mature and slow-growing; at $52B market cap in a category that compounds mid-single-digits, there is no realistic path to a fast multibagger. The quality lever (software/ARR mix, higher-margin recurring revenue) is the real upside, and it moves slowly.
- Reinvestment runway: disciplined — modest capex (~$186M FY25, ~2% of sales), heavy return of cash via buybacks and a ~1.2% dividend. This is a mature-capital-allocation profile, not a reinvest-for-hypergrowth one.
Exponential Potential: Low (3/10). Own ROK for durable mid-single-digit compounding + a slow margin/mix upgrade, not for a fast multibagger. A small, accelerating automation name would score far higher; a $52B mature leader does not.
5. Financials (real numbers — FMP annual/quarterly)
- Revenue: FY25 $8.34B, +1.0% (FY24 $8.26B; down from FY23's cyclical peak of $9.06B). The 2024–25 trough reflects a genuine automation capex downcycle; the recovery is now underway.
- Quarterly trajectory (the recovery): Q1 FY25 $1.88B → Q2 $2.00B → Q3 $2.14B → Q4 $2.32B → Q1 FY26 $2.11B → Q2 FY26 $2.24B (+12% YoY reported, +9% organic). Sequential and YoY re-acceleration is real.
- Margins: gross 52.5% TTM, EBITDA margin ~18.8%, operating ~19%, net 12.4% TTM. Q2 FY26 Enterprise operating margin was 22.5% (up from 19.0% a year ago) on volume, price/cost, and mix — margins are expanding as sales recover.
- Earnings — read this carefully: FY25 GAAP diluted EPS was $7.67, depressed by a large Q4 non-operating charge (Q4 GAAP EPS just $1.23). The run-rate is much higher: adjusted EPS was $3.30 in Q2 FY26 alone (+32% YoY), and management guides FY26 adjusted EPS to $12.50–$13.10. Trailing GAAP P/E (~49×) therefore overstates the true multiple; the forward figures (§6) are the fair lens.
- Cash flow: FY25 operating CF $1.54B, capex −$186M, FCF ~$1.36B (16% FCF margin) — strong, high-quality conversion. FCF covers the dividend (~$591M) and buybacks comfortably.
- Balance sheet: total debt ~$3.65B, net debt ~$3.18B, net-debt/EBITDA ~2.2× — moderate leverage for a cyclical; interest coverage ~12×; investment-grade. ROE ~30%, ROIC ~16% (management cites adjusted ROIC 17.2%).
6. Valuation — priced in or room?
ROK is not cheap. Trailing GAAP P/E of ~49× is distorted by the FY25 charge; the honest lens is forward, and even there the stock is ~36× FY26E ($12.98) → ~32× FY27E ($14.53) → ~26× FY30E ($18.49). On management's own FY26 adjusted-EPS guide ($12.50–$13.10) the multiple is ~37–38×. EV/EBITDA is 34× and EV/sales 6.4× — rich absolute levels for a company growing revenue ~5%. The forward PEG (~4×) confirms you are paying up for quality and cyclical recovery, not for growth.
The bull's defense is that (a) margins and the software/ARR mix keep improving, lifting EPS faster than revenue, and (b) the capex cycle has further to run. Both are plausible, but neither makes the current multiple a bargain. Street targets (context): consensus $475, high $525, low $410, median $490 — and the analyst grade split is 12 Buy / 25 Hold / 2 Sell = "Hold." The Street itself is not enthusiastic. Our ~$465 base FV sits right in that consensus band. This is a quality-cyclical-at-full-price — a Watch, not a buy, at $471.70.
7. Technicals (computed from EOD price history)
- Trend: up. $471.70 sits above the 50-DMA ($448) and 200-DMA ($399), with the 50 above the 200 (golden-cross posture). MACD +9.7 (positive).
- Location: −4.7% off the 52-week high ($495), +43.5% off the 52-week low ($329) — a leadership industrial near its highs, with a shallow max drawdown (−4.7% from peak).
- Momentum: RSI(14) 56 — constructive but not overbought (<70); no stretched-entry warning, but no oversold bargain either.
- Relative strength: ROK +39.3% 12-mo vs SPY +20.6% and QQQ +30.3%; +27.9% 3-mo vs SPY +13.7%. Outperforming both the market and the Nasdaq over 12 months — the cyclical-recovery trade is working.
- Read: technicals confirm the recovery but offer no valuation help. The stock is near highs, not on sale. A pullback toward the rising 50-DMA (~$448) or below would be a lower-risk entry consistent with the Watch stance.
8. Moat & competitive position
Rockwell's moat is real and durable: (1) the Allen-Bradley / Logix installed base — decades of controllers embedded in North-American factories create enormous switching costs; engineers are trained on the ecosystem and rip-and-replace is costly and risky; (2) a broad automation portfolio (devices + control software + lifecycle services) that lets it sell the whole stack; (3) a software/ARR pivot (Software & Control +20% YoY, ARR +6%) that gradually raises recurring, higher-margin revenue. The offset: it is a cyclical, capex-driven business with formidable global competitors (Siemens, Schneider Electric, ABB, Emerson, Honeywell) — several larger and more diversified than Rockwell, which is the automation pure-play.
Peer set (FMP-supplied, US industrial compounders — market cap): AMETEK $54B, Fastenal $56B, W.W. Grainger $63B, HEICO $50B, Ingersoll Rand $32B, Otis $28B, Paychex $38B, Roper $37B, Waste Connections $43B, Xylem $28B. (Note: FMP's peer list is broad "quality industrials," not automation pure-plays; ROK's truest comps are Siemens/Schneider/ABB/Emerson, not shown here.) Against this quality-industrial cohort ROK carries a premium multiple justified only by its moat and margin/mix trajectory.
9. Management, capital allocation & guidance
- Capital allocation: disciplined and shareholder-friendly — modest capex (~2% of sales), a growing dividend (~1.2% yield, ~55% payout), and active buybacks (1.2M shares / $454M repurchased in Q2 FY26; ~$318M remained on the authorization). Leverage held at a moderate ~2.2× net-debt/EBITDA. In April 2026 management dissolved the Sensia JV and is excluding the divested businesses from second-half guidance — portfolio pruning, not empire-building.
- Insider activity: routine. Recent Form 4s show small officer sales (SVP Lifecycle Services, Chief IP Counsel) at $426–$460, mostly tied to option exercises/RSU vesting, plus a director RSU award — normal compensation-driven activity, no alarming discretionary selling cluster in the sampled window (through 2026-07-01).
- Management's own guidance (SEC 8-K, Q2 FY26 earnings release 2026-05-05 — half-weighted; this is management's self-interested framing): management raised FY26 guidance to reported sales growth 5–9% (from 3–7%), organic sales growth 5–9% (from 2–6%), reported-sales midpoint ~$8.9B, diluted EPS $11.88–$12.48 (from $10.75–$11.55) and adjusted EPS $12.50–$13.10 (from $11.40–$12.20). CEO Blake Moret cited "improving demand in warehouse automation, data center, semiconductor, and energy," while noting "capital investment remains muted in other key verticals." Total ARR +6% YoY. Treat as management's own book, half-weighted — but the raise is corroborated by the actual Q2 print (+12% sales, adj. EPS +32%), which lends it credibility.
10. Catalysts & what to watch
- Next earnings: 2026-08-05 (Q3 FY26; Street EPS $3.34, revenue ~$2.24B). Key lines: organic order growth, ARR growth, and Software & Control margin — the tells for whether the recovery is broadening or stalling.
- Capex cycle: the single biggest swing factor. Watch orders/book-to-bill and management's vertical-by-vertical demand commentary (data center, semi, warehouse strong; others "muted").
- Software/ARR mix: continued double-digit Software & Control growth and rising ARR = the quality-upgrade thesis working.
- Margins: whether Enterprise operating margin holds the mid-20s% as volume recovers.
- Sensia divestiture: clean read-through on the second-half comparable-period adjustments.
Thesis tripwires (what would change the call): two consecutive quarters of organic order decline; ARR growth stalling below mid-single-digits; Enterprise operating margin compressing back toward high-teens; or a multiple re-rating that finally makes the risk/reward attractive (a move toward the ~$400s would warrant an upgrade look).
11. Key risks
- Cyclicality (structural): automation demand tracks industrial capex; a slowdown hits orders, revenue, and the rich multiple simultaneously — the classic cyclical double-whammy. This is the core reason for the Watch.
- Valuation / de-rating: ~36× forward EPS for ~5% revenue growth leaves little margin for a demand or margin disappointment.
- Leverage + beta: net-debt/EBITDA ~2.2× and beta 1.56 amplify downside in a risk-off or recessionary tape.
- Geographic concentration: ~63% North America — a US-capex tailwind today, but a concentration risk if domestic manufacturing investment cools.
- Competition: larger, more diversified global rivals (Siemens, Schneider, ABB, Emerson) can pressure pricing and share.
- No expert coverage: the Synthos KB has zero traceable expert views on ROK — this call has no conviction-track corroboration and rests entirely on fundamentals/quant.
12. Verdict, position sizing & monitoring
Watch. Rockwell is a genuinely high-quality, wide-moat US automation franchise executing a clean cyclical recovery — 52% gross margin, ~30% ROE, expanding Enterprise operating margin (22.5% in Q2 FY26), a raised FY26 guide, and a slow but real software/ARR mix-upgrade. What holds us back is price: at ~36× forward EPS and 34× EV/EBITDA for ~5% revenue growth, the market already pays full value, and the Street's own 12 Buy / 25 Hold / 2 Sell grade agrees this is not a screaming opportunity. Combine a rich multiple with beta 1.56, ~2.2× leverage, and a cyclical order book, and the risk/reward here is balanced-to-slightly-negative, not compelling.
- Sizing: watchlist / small satellite only. No need to own it at $471.70. Build a position on either (a) a valuation reset toward the low-$400s / mid-20s× forward, or (b) confirmed order re-acceleration that upgrades the growth rate.
- Monitoring: re-underwrite on the §10 tripwires; formal re-score each earnings print (next 2026-08-05). This verdict is logged as a tracked Synthos call as of 2026-07-03 at $471.70.
- Single biggest risk: a cyclical capex downturn that rolls orders over while the stock still carries a ~36× forward multiple.
Provenance & disclosures
- Traceability: 0 KB claims, breadth 0 — there is no expert coverage of ROK in the Synthos knowledge base. This note is explicitly fundamentals- and quant-driven, and says so. Fabricated conviction is structurally impossible (claim-ID reconciliation), and none is claimed here.
- Data as-of: fundamentals 2026-03-31 (Q2 FY26) · estimates & prices 2026-07-02/03 · no expert claims. Forward figures are analyst consensus (FMP) or management guidance, labeled as estimates.
- Management caveat: management's raised FY26 guidance (SEC 8-K, 2026-05-05) is management's own book, half-weighted by design; it is corroborated by the actual Q2 FY26 print.
- Not investment advice. Independent research, educational and informational only, never personalized. Hypothetical/forward figures are labeled; the only performance numbers Synthos will headline are the live, real-money Flagship's.
- Version: 2026-07-03. Prior versions available via the deep-dive version dropdown ("based on the info at the time").